Literature DB >> 27560842

Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.

Jayant Arora1,2, Yue Hu1,2, Reza Esfandiary3, Hasige A Sathish3, Steven M Bishop3, Sangeeta B Joshi1,2, C Russell Middaugh1,2, David B Volkin1,2, David D Weis1,4.   

Abstract

Concentration-dependent reversible self-association (RSA) of monoclonal antibodies (mAbs) poses a challenge to their pharmaceutical development as viable candidates for subcutaneous delivery. While the role of the antigen-binding fragment (Fab) in initiating RSA is well-established, little evidence supports the involvement of the crystallizable fragment (Fc). In this report, a variety of biophysical tools, including hydrogen exchange mass spectrometry, are used to elucidate the protein interface of such non-covalent protein-protein interactions. Using dynamic and static light scattering combined with viscosity measurements, we find that an IgG1 mAb (mAb-J) undergoes RSA primarily through electrostatic interactions and forms a monomer-dimer-tetramer equilibrium. We provide the first direct experimental mapping of the interface formed between the Fab and Fc domains of an antibody at high protein concentrations. Charge distribution heterogeneity between the positively charged interface spanning complementarity-determining regions CDR3H and CDR2L in the Fab and a negatively charged region in CH3/Fc domain mediates the RSA of mAb-J. When arginine and NaCl are added, they disrupt RSA of mAb-J and decrease the solution viscosity. Fab-Fc domain interactions between mAb monomers may promote the formation of large transient antibody complexes that ultimately cause increases in solution viscosity. Our findings illustrate how limited specific arrangements of amino-acid residues can cause mAbs to undergo RSA at high protein concentrations and how conserved regions in the Fc portion of the antibody can also play an important role in initiating weak and transient protein-protein interactions.

Entities:  

Keywords:  Hydrogen exchange; monoclonal antibody; protein aggregation; protein-protein interactions; reversible self-association

Mesh:

Substances:

Year:  2016        PMID: 27560842      PMCID: PMC5098451          DOI: 10.1080/19420862.2016.1222342

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  64 in total

1.  Conformational Analysis of Proteins in Highly Concentrated Solutions by Dialysis-Coupled Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Damian Houde; Zeinab E Nazari; George M Bou-Assaf; Andrew S Weiskopf; Kasper D Rand
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-09       Impact factor: 3.109

2.  Role of arginine in the stabilization of proteins against aggregation.

Authors:  Brian M Baynes; Daniel I C Wang; Bernhardt L Trout
Journal:  Biochemistry       Date:  2005-03-29       Impact factor: 3.162

3.  Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Authors:  Damian Houde; Yucai Peng; Steven A Berkowitz; John R Engen
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

4.  Immunoactive two-dimensional self-assembly of monoclonal antibodies in aqueous solution revealed by atomic force microscopy.

Authors:  Shinichiro Ido; Hirokazu Kimiya; Kei Kobayashi; Hiroaki Kominami; Kazumi Matsushige; Hirofumi Yamada
Journal:  Nat Mater       Date:  2014-01-19       Impact factor: 43.841

5.  Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.

Authors:  James C Geoghegan; Ryan Fleming; Melissa Damschroder; Steven M Bishop; Hasige A Sathish; Reza Esfandiary
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

6.  Stabilization of protein structure by sugars.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

7.  The stabilization of proteins by sucrose.

Authors:  J C Lee; S N Timasheff
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

8.  Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.

Authors:  Shigeki Matsumiya; Yoshiki Yamaguchi; Jun-ichi Saito; Mayumi Nagano; Hiroaki Sasakawa; Shizuo Otaki; Mitsuo Satoh; Kenya Shitara; Koichi Kato
Journal:  J Mol Biol       Date:  2007-02-22       Impact factor: 5.469

Review 9.  Alternative modulation of protein-protein interactions by small molecules.

Authors:  Gerhard Fischer; Maxim Rossmann; Marko Hyvönen
Journal:  Curr Opin Biotechnol       Date:  2015-05-15       Impact factor: 9.740

10.  Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses.

Authors:  Marisa K Joubert; Martha Hokom; Catherine Eakin; Lei Zhou; Meghana Deshpande; Matthew P Baker; Theresa J Goletz; Bruce A Kerwin; Naren Chirmule; Linda O Narhi; Vibha Jawa
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

View more
  24 in total

1.  Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.

Authors:  Qun Du; Melissa Damschroder; Timothy M Pabst; Alan K Hunter; William K Wang; Haibin Luo
Journal:  MAbs       Date:  2019-04-14       Impact factor: 5.857

Review 2.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

3.  Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development.

Authors:  Martin Domnowski; Jan Jaehrling; Wolfgang Frieß
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

4.  Charge Shielding Prevents Aggregation of Supercharged GFP Variants at High Protein Concentration.

Authors:  Joshua R Laber; Barton J Dear; Matheus L Martins; Devin E Jackson; Andrea DiVenere; Jimmy D Gollihar; Andrew D Ellington; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  Mol Pharm       Date:  2017-09-18       Impact factor: 4.939

5.  Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.

Authors:  Yulei Zhang; Lina Wu; Priyanka Gupta; Alec A Desai; Matthew D Smith; Lilia A Rabia; Seth D Ludwig; Peter M Tessier
Journal:  Mol Pharm       Date:  2020-06-11       Impact factor: 4.939

6.  Cluster Formation and Entanglement in the Rheology of Antibody Solutions.

Authors:  Nelson Ramallo; Subhash Paudel; Jeremy Schmit
Journal:  J Phys Chem B       Date:  2019-04-25       Impact factor: 2.991

7.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

8.  Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.

Authors:  Jessica J Hung; Barton J Dear; Aileen K Dinin; Ameya U Borwankar; Sumarth K Mehta; Thomas T Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2018-04-30       Impact factor: 4.200

9.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

Review 10.  The Protein Folding Problem: The Role of Theory.

Authors:  Roy Nassar; Gregory L Dignon; Rostam M Razban; Ken A Dill
Journal:  J Mol Biol       Date:  2021-07-03       Impact factor: 6.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.